{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:24:18Z","timestamp":1786951458310,"version":"build-2736575974"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010225","name":"MOST | NSFC | National Outstanding Youth Foundation of China","doi-asserted-by":"publisher","award":["32321002"],"award-info":[{"award-number":["32321002"]}],"id":[{"id":"10.13039\/501100010225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32430028"],"award-info":[{"award-number":["32430028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31830052"],"award-info":[{"award-number":["31830052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271768"],"award-info":[{"award-number":["82271768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"MOST | National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1301401"],"award-info":[{"award-number":["2021YFA1301401"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Development Project of Hangzhou","award":["20241029Y037"],"award-info":[{"award-number":["20241029Y037"]}]},{"name":"Medical and Health Science and Technology Program Projects of Zhejiang Province","award":["2025KY1113"],"award-info":[{"award-number":["2025KY1113"]}]},{"DOI":"10.13039\/501100017577","name":"MOST | NSFC | NSFC-Zhejiang Joint Fund | \u6d59\u6c5f\u7701\u79d1\u5b66\u6280\u672f\u5385 | Basic Public Welfare Research Program of Zhejiang Province","doi-asserted-by":"publisher","award":["Q22C079669"],"award-info":[{"award-number":["Q22C079669"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>EGFR hotspot mutations (mEGFR), including primary L858R, exon 19 deletion, and secondary T790M, are pivotal oncogenic drivers in human non-small cell lung cancer (NSCLC). At the same time, NSCLC resistance to third-generation tyrosine kinase inhibitors (TKIs) is a major clinical challenge and remains mechanistically unresolved. Here, we uncover a previously unrecognized tumor cell-intrinsic mechanism in which mutant EGFR (mEGFR) exploits innate immune signaling via the cGAS\u2013STING\u2013TBK1 pathway to sustain oncogenic signaling and therapeutic resistance. Mechanistically, mutant EGFR kinase aberrantly associates with STING signalosomes and phosphorylates STING (Y245\/Y314) and TBK1 (Y577\/Y677), stabilizing and hyperactivating TBK1 and establishing an unexpected kinase loop critical for DNA damage repair. Genetic or pharmacological disruption of mEGFR\u2013STING\u2013TBK1 coupling sensitizes resistant patient-derived NSCLC organoids to chemotherapy. Combining TBK1 inhibition with cisplatin suppressed mEGFR-driven tumors in murine models of spontaneous and immunocompetent NSCLC and in patient-derived organoids. Our findings suggest a new function of cGAS\u2013STING in DNA damage tolerance, its paradoxical exploitation by oncogenic driver mutations, and an innate immune therapeutic vulnerability in NSCLC.<\/jats:p>","DOI":"10.1038\/s44318-026-00856-3","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:50:44Z","timestamp":1783698644000},"page":"5759-5792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oncogenic EGFR rewires STING-TBK1 signalosomes to license DNA damage tolerance in NSCLC"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7401-9359","authenticated-orcid":false,"given":"Qin","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5959-4223","authenticated-orcid":false,"given":"Chen","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3175-5310","authenticated-orcid":false,"given":"Qingzhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9179-6539","authenticated-orcid":false,"given":"Fei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengduo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunqi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4418-0811","authenticated-orcid":false,"given":"Xin-Hua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-2191","authenticated-orcid":false,"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7081-9308","authenticated-orcid":false,"given":"Hai","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3262-2587","authenticated-orcid":false,"given":"Tingbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5167-1344","authenticated-orcid":false,"given":"Penghong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9178-5493","authenticated-orcid":false,"given":"Bing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-5443","authenticated-orcid":false,"given":"Pinglong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"856_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2013.01.039","volume":"50","author":"T Abe","year":"2013","unstructured":"Abe T, Harashima A, Xia T, Konno H, Konno K, Morales A, Ahn J, Gutman D, Barber GN (2013) STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell 50:5\u201315","journal-title":"Mol Cell"},{"key":"856_CR2","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/art.40002","volume":"69","author":"J An","year":"2017","unstructured":"An J, Durcan L, Karr RM, Briggs TA, Rice GI, Teal TH, Woodward JJ, Elkon KB (2017) Expression of cyclic GMP-AMP synthase in patients with systemic lupus erythematosus. Arthritis Rheumatol 69:800\u2013807","journal-title":"Arthritis Rheumatol"},{"key":"856_CR3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccr.2014.02.025","volume":"25","author":"CL Arteaga","year":"2014","unstructured":"Arteaga CL, Engelman JA (2014) ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell 25:282\u2013303","journal-title":"Cancer Cell"},{"key":"856_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/0008-5472.CAN-14-3619","volume":"76","author":"JR Baird","year":"2016","unstructured":"Baird JR, Friedman D, Cottam B, Dubensky TW, Kanne DB, Bambina S, Bahjat K, Crittenden MR, Gough MJ (2016) Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors. Cancer Res 76:50\u201361","journal-title":"Cancer Res"},{"key":"856_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cell.2018.08.027","volume":"174","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Cantley LC (2018) The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell 174:1347\u20131360","journal-title":"Cell"},{"key":"856_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Ngo B, Laughney AM, Cavallo J-A, Murphy CJ, Ly P, Shah P, Sriram RK, Watkins TBK, Taunk NK et al (2018) Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553:467\u2013472","journal-title":"Nature"},{"key":"856_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26240-9","volume":"12","author":"D Banerjee","year":"2021","unstructured":"Banerjee D, Langberg K, Abbas S, Odermatt E, Yerramothu P, Volaric M, Reidenbach MA, Krentz KJ, Rubinstein CD, Brautigan DL et al (2021) A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signaling. Nat Commun 12:6207","journal-title":"Nat Commun"},{"key":"856_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C et al (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108\u2013112","journal-title":"Nature"},{"key":"856_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40349-z","volume":"14","author":"D Bian","year":"2023","unstructured":"Bian D, Sun L, Hu J, Duan L, Xia H, Zhu X, Sun F, Zhang L, Yu H, Xiong Y et al (2023) Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study. Nat Commun 14:4655","journal-title":"Nat Commun"},{"key":"856_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ccell.2019.03.002","volume":"35","author":"MT Blasco","year":"2019","unstructured":"Blasco MT, Navas C, Mart\u00edn-Serrano G, Gra\u00f1a-Castro O, Lechuga CG, Mart\u00edn-D\u00edaz L, Djurec M, Li J, Morales-Cacho L, Esteban-Burgos L et al (2019) Complete regression of advanced pancreatic ductal adenocarcinomas upon combined inhibition of EGFR and C-RAF. Cancer Cell 35:573\u2013587.e6","journal-title":"Cancer Cell"},{"key":"856_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15252\/embj.201696164","volume":"37","author":"C Bodur","year":"2018","unstructured":"Bodur C, Kazyken D, Huang K, Ekim Ustunel B, Siroky KA, Tooley AS, Gonzalez IE, Foley DH, Acosta-Jaquez HA, Barnes TM et al (2018) The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists. EMBO J 37:19\u201338","journal-title":"EMBO J"},{"key":"856_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","volume":"33","author":"C Chen","year":"2023","unstructured":"Chen C, Xu P (2023) Cellular functions of cGAS-STING signaling. Trends Cell Biol 33:630\u2013648","journal-title":"Trends Cell Biol"},{"key":"856_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tcb.2022.06.010","volume":"33","author":"EN Chin","year":"2023","unstructured":"Chin EN, Sulpizio A, Lairson LL (2023) Targeting STING to promote antitumor immunity. Trends Cell Biol 33:189\u2013203","journal-title":"Trends Cell Biol"},{"key":"856_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35962-x","volume":"14","author":"J Chmielecki","year":"2023","unstructured":"Chmielecki J, Mok T, Wu Y-L, Han J-Y, Ahn M-J, Ramalingam SS, John T, Okamoto I, Yang JC-H, Shepherd FA et al (2023) Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial. Nat Commun 14:1071","journal-title":"Nat Commun"},{"key":"856_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","volume":"30","author":"KW Chung","year":"2019","unstructured":"Chung KW, Dhillon P, Huang S, Sheng X, Shrestha R, Qiu C, Kaufman BA, Park J, Pei L, Baur J et al (2019) Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis. Cell Metab 30:784\u2013799.e5","journal-title":"Cell Metab"},{"key":"856_CR16","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1158\/0008-5472.CAN-17-0829","volume":"77","author":"JM Cooper","year":"2017","unstructured":"Cooper JM, Ou Y-H, McMillan EA, Vaden RM, Zaman A, Bodemann BO, Makkar G, Posner BA, White MA (2017) TBK1 provides context-selective support of the activated AKT\/mTOR pathway in lung cancer. Cancer Res 77:5077\u20135094","journal-title":"Cancer Res"},{"key":"856_CR17","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","volume":"4","author":"DAE Cross","year":"2014","unstructured":"Cross DAE, Ashton SE, Ghiorghiu S, Eberlein C, Nebhan CA, Spitzler PJ, Orme JP, Finlay MRV, Ward RA, Mellor MJ et al (2014) AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov 4:1046","journal-title":"Cancer Discov"},{"key":"856_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ni.2239","volume":"13","author":"J Cui","year":"2012","unstructured":"Cui J, Li Y, Zhu L, Liu D, Songyang Z, Wang HY, Wang R-F (2012) NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol 13:387\u2013395","journal-title":"Nat Immunol"},{"key":"856_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-pathol-011110-130206","volume":"6","author":"G Da Cunha Santos","year":"2011","unstructured":"Da Cunha Santos G, Shepherd FA, Tsao MS (2011) EGFR mutations and lung cancer. Annu Rev Pathol Mech Dis 6:49\u201369","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"856_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16014-0","volume":"11","author":"M Deng","year":"2020","unstructured":"Deng M, Tam JW, Wang L, Liang K, Li S, Zhang L, Guo H, Luo X, Zhang Y, Petrucelli A et al (2020) TRAF3IP3 negatively regulates cytosolic RNA induced anti-viral signaling by promoting TBK1 K48 ubiquitination. Nat Commun 11:2193","journal-title":"Nat Commun"},{"key":"856_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1101\/gad.289769.116","volume":"31","author":"E Erdal","year":"2017","unstructured":"Erdal E, Haider S, Rehwinkel J, Harris AL, McHugh PJ (2017) A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1. Genes Dev 31:353\u2013369","journal-title":"Genes Dev"},{"key":"856_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nn.4000","volume":"18","author":"A Freischmidt","year":"2015","unstructured":"Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M\u00fcller K, Marroquin N, Nordin F, H\u00fcbers A, Weydt P et al (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18:631\u2013636","journal-title":"Nat Neurosci"},{"key":"856_CR23","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31:1869\u20131883","journal-title":"Oncogene"},{"key":"856_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","volume":"607","author":"C Hong","year":"2022","unstructured":"Hong C, Schubert M, Tijhuis AE, Requesens M, Roorda M, van den Brink A, Ruiz LA, Bakker PL, van der Sluis T, Pieters W et al (2022) cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature 607:366\u2013373","journal-title":"Nature"},{"key":"856_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/2159-8290.CD-19-0837","volume":"10","author":"L Hu","year":"2020","unstructured":"Hu L, Xie H, Liu X, Potjewyd F, James LI, Wilkerson EM, Herring LE, Xie L, Chen X, Cabrera JC et al (2020) TBK1 is a synthetic lethal target in cancer with VHL loss. Cancer Discov 10:460","journal-title":"Cancer Discov"},{"key":"856_CR80","doi-asserted-by":"crossref","unstructured":"Inukai M, Toyooka S, Ito S, Asano H, Ichihara S, Soh J, Suehisa H, Ouchida M, Aoe K, Aoe M et al (2006) Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer. Cancer Res 66:7854\u20137858","DOI":"10.1158\/0008-5472.CAN-06-1951"},{"key":"856_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biopha.2016.01.043","volume":"79","author":"Y Jia","year":"2016","unstructured":"Jia Y, Zhou D, Jia Q, Ying Y, Chen S (2016) Synergistic and attenuated effect of HSS in combination treatment with docetaxel plus cisplatin in human non-small-cell lung SPC-A-1 tumor xenograft. Biomed Pharmacother 79:27\u201334","journal-title":"Biomed Pharmacother"},{"key":"856_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573\u2013584","journal-title":"Nat Rev Cancer"},{"key":"856_CR79","doi-asserted-by":"crossref","unstructured":"Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T (2004) Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 64:8919\u20138923","DOI":"10.1158\/0008-5472.CAN-04-2818"},{"key":"856_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon J, Bakhoum SF (2020) The cytosolic DNA-sensing cGAS-STING pathway in cancer. Cancer Discov 10:26\u201339","journal-title":"Cancer Discov"},{"key":"856_CR29","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41556-018-0229-6","volume":"20","author":"E Lafont","year":"2018","unstructured":"Lafont E, Draber P, Rieser E, Reichert M, Kupka S, de Miguel D, Draberova H, von M\u00e4ssenhausen A, Bhamra A, Henderson S et al (2018) TBK1 and IKK\u03b5 prevent TNF-induced cell death by RIPK1 phosphorylation. Nat Cell Biol 20:1389\u20131399","journal-title":"Nat Cell Biol"},{"key":"856_CR30","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-15-1456","volume":"76","author":"H Lemos","year":"2016","unstructured":"Lemos H, Mohamed E, Huang L, Ou R, Pacholczyk G, Arbab AS, Munn D, Mellor AL (2016) STING promotes the growth of tumors characterized by low antigenicity via IDO activation. Cancer Res 76:2076\u20132081","journal-title":"Cancer Res"},{"key":"856_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01566-5","volume":"8","author":"H Liang","year":"2017","unstructured":"Liang H, Deng L, Hou Y, Meng X, Huang X, Rao E, Zheng W, Mauceri H, Mack M, Xu M et al (2017) Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat Commun 8:1736","journal-title":"Nat Commun"},{"key":"856_CR32","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.cmet.2021.07.009","volume":"33","author":"R Liu","year":"2021","unstructured":"Liu R, Li J, Shao J, Lee J-H, Qiu X, Xiao Y, Zhang B, Hao Y, Li M, Chen Q (2021) Innate immune response orchestrates phosphoribosyl pyrophosphate synthetases to support DNA repair. Cell Metab 33:2076\u20132089.e9","journal-title":"Cell Metab"},{"key":"856_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa2630","volume":"347","author":"S Liu","year":"2015","unstructured":"Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, Du F, Ren J, Wu Y-T, Grishin NV et al (2015) Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347:aaa2630","journal-title":"Science"},{"key":"856_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.chom.2017.05.010","volume":"21","author":"S Liu","year":"2017","unstructured":"Liu S, Chen S, Li X, Wu S, Zhang Q, Jin Q, Hu L, Zhou R, Yu Z, Meng F et al (2017) Lck\/Hck\/Fgr-mediated tyrosine phosphorylation negatively regulates TBK1 to restrain innate antiviral responses. Cell Host Microbe 21:754\u2013768.e5","journal-title":"Cell Host Microbe"},{"key":"856_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.tcb.2025.08.007","volume":"36","author":"S Liu","year":"2026","unstructured":"Liu S, Wang A, Chen C, Xu P (2026) Organelle-specific signaling of cGAS-STING. Trends Cell Biol 36:355\u2013376","journal-title":"Trends Cell Biol"},{"key":"856_CR36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409493121","volume":"121","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang A, Chen C, Zhang Q, Shen Q, Zhang D, Xiao X, Chen S, Lian L, Le Z et al (2024) Microglial cGAS-STING signaling underlies glaucoma pathogenesis. Proc Natl Acad Sci USA 121:e2409493121","journal-title":"Proc Natl Acad Sci USA"},{"key":"856_CR37","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S1470-2045(22)00382-5","volume":"23","author":"S Lu","year":"2022","unstructured":"Lu S, Wu L, Jian H, Chen Y, Wang Q, Fang J, Wang Z, Hu Y, Sun M, Han L et al (2022) Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial. Lancet Oncol 23:1167\u20131179","journal-title":"Lancet Oncol"},{"key":"856_CR38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.chembiol.2023.05.005","volume":"30","author":"Q-M Lv","year":"2023","unstructured":"Lv Q-M, Lei H-M, Wang S-Y, Zhang K-R, Tang Y-B, Shen Y, Lu L-M, Chen H-Z, Zhu L (2023) Cancer cell-autonomous cGAS-STING response confers drug resistance. Cell Chem Biol 30:591\u2013605.e4","journal-title":"Cell Chem Biol"},{"key":"856_CR39","doi-asserted-by":"crossref","unstructured":"Lynch TJ, Okimoto RA, Supko JG, Settleman J (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129\u20132139","DOI":"10.1056\/NEJMoa040938"},{"key":"856_CR40","doi-asserted-by":"crossref","unstructured":"Makoto M, Akira I, Kunihiko K, Shunichi S, Satoshi O, Hiroshi I, Akihiko G, Masao H, Hirohisa Y, Ichiro K et al (2010) Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362:2380\u20132388","DOI":"10.1056\/NEJMoa0909530"},{"key":"856_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1600-065X.2012.01101.x","volume":"246","author":"KW McCool","year":"2012","unstructured":"McCool KW, Miyamoto S (2012) DNA damage-dependent NF-\u03baB activation: NEMO turns nuclear signaling inside out. Immunol Rev 246:311\u2013326","journal-title":"Immunol Rev"},{"key":"856_CR42","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1016\/j.molcel.2021.07.040","volume":"81","author":"F Meng","year":"2021","unstructured":"Meng F, Yu Z, Zhang D, Chen S, Guan H, Zhou R, Wu Q, Zhang Q, Liu S, Venkat Ramani MK et al (2021) Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity. Mol Cell 81:4147\u20134164.e7","journal-title":"Mol Cell"},{"key":"856_CR43","doi-asserted-by":"publisher","first-page":"e201250","DOI":"10.1001\/jamaoncol.2020.1250","volume":"6","author":"S Miyamoto","year":"2020","unstructured":"Miyamoto S, Azuma K, Ishii H, Bessho A, Hosokawa S, Fukamatsu N, Kunitoh H, Ishii M, Tanaka H, Aono H et al (2020) Low-dose erlotinib treatment in elderly or frail patients with EGFR mutation-positive non-small cell lung cancer: a multicenter phase 2 trial. JAMA Oncol 6:e201250","journal-title":"JAMA Oncol"},{"key":"856_CR44","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molcel.2011.01.019","volume":"41","author":"Y-H Ou","year":"2011","unstructured":"Ou Y-H, Torres M, Ram R, Formstecher E, Roland C, Cheng T, Brekken R, Wurz R, Tasker A, Polverino T et al (2011) TBK1 directly engages Akt\/PKB survival signaling to support oncogenic transformation. Mol Cell 41:458\u2013470","journal-title":"Mol Cell"},{"key":"856_CR45","doi-asserted-by":"publisher","first-page":"7695","DOI":"10.1158\/0008-5472.CAN-07-0484","volume":"67","author":"D Padr\u00f3n","year":"2007","unstructured":"Padr\u00f3n D, Sato M, Shay JW, Gazdar AF, Minna JD, Roth MG (2007) Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized. Cancer Res 67:7695\u20137702","journal-title":"Cancer Res"},{"key":"856_CR46","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1056\/NEJMoa2306434","volume":"389","author":"D Planchard","year":"2023","unstructured":"Planchard D, J\u00e4nne PA, Cheng Y, Yang JC-H, Yanagitani N, Kim S-W, Sugawara S, Yu Y, Fan Y, Geater SL et al (2023) Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC. N Engl J Med 389:1935\u20131948","journal-title":"N Engl J Med"},{"key":"856_CR47","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1200\/JCO.2017.74.7576","volume":"36","author":"SS Ramalingam","year":"2018","unstructured":"Ramalingam SS, Yang JC-H, Lee CK, Kurata T, Kim D-W, John T, Nogami N, Ohe Y, Mann H, Rukazenkov Y et al (2018) Osimertinib as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer. J Clin Oncol 36:841\u2013849","journal-title":"J Clin Oncol"},{"key":"856_CR48","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.immuni.2016.04.002","volume":"44","author":"A Roers","year":"2016","unstructured":"Roers A, Hiller B, Hornung V (2016) Recognition of endogenous nucleic acids by the innate immune system. Immunity 44:739\u2013754","journal-title":"Immunity"},{"key":"856_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","volume":"79","author":"R Roskoski","year":"2014","unstructured":"Roskoski R (2014) The ErbB\/HER family of protein-tyrosine kinases and cancer. Pharm Res 79:34\u201374","journal-title":"Pharm Res"},{"key":"856_CR50","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.phrs.2018.11.014","volume":"139","author":"R Roskoski","year":"2019","unstructured":"Roskoski R (2019) Small molecule inhibitors targeting the EGFR\/ErbB family of protein-tyrosine kinases in human cancers. Pharmacol Res 139:395\u2013411","journal-title":"Pharmacol Res"},{"key":"856_CR51","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrc.2017.84","volume":"17","author":"J Rotow","year":"2017","unstructured":"Rotow J, Bivona TG (2017) Understanding and targeting resistance mechanisms in NSCLC. Nat Rev Cancer 17:637\u2013658","journal-title":"Nat Rev Cancer"},{"key":"856_CR52","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","volume":"9","author":"T Sen","year":"2019","unstructured":"Sen T, Rodriguez BL, Chen L, Corte CMD, Morikawa N, Fujimoto J, Cristea S, Nguyen T, Diao L, Li L et al (2019) Targeting DNA Damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer. Cancer Discov 9:646\u2013661","journal-title":"Cancer Discov"},{"key":"856_CR53","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1126\/science.1081315","volume":"300","author":"S Sharma","year":"2003","unstructured":"Sharma S, tenOever BR, Grandvaux N, Zhou G-P, Lin R, Hiscott J (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148\u20131151","journal-title":"Science"},{"key":"856_CR54","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1124\/pr.111.005637","volume":"64","author":"D-W Shen","year":"2012","unstructured":"Shen D-W, Pouliot LM, Hall MD, Gottesman MM (2012) Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharm Rev 64:706\u2013721","journal-title":"Pharm Rev"},{"key":"856_CR55","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","volume":"22","author":"ZH Siddik","year":"2003","unstructured":"Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265\u20137279","journal-title":"Oncogene"},{"key":"856_CR56","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41586-023-05704-6","volume":"615","author":"Y Sun","year":"2023","unstructured":"Sun Y, Revach O-Y, Anderson S, Kessler EA, Wolfe CH, Jenney A, Mills CE, Robitschek EJ, Davis TGR, Kim S et al (2023) Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature 615:158\u2013167","journal-title":"Nature"},{"key":"856_CR57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tcb.2013.11.002","volume":"24","author":"A Tomas","year":"2014","unstructured":"Tomas A, Futter CE, Eden ER (2014) EGF receptor trafficking: consequences for signaling and cancer. Trends Cell Biol 24:26\u201334","journal-title":"Trends Cell Biol"},{"key":"856_CR58","doi-asserted-by":"crossref","unstructured":"Tooley AS, Kazyken D, Bodur C, Gonzalez IE, Fingar DC (2021) The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt. J Biol Chem 297:100942","DOI":"10.1016\/j.jbc.2021.100942"},{"key":"856_CR59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41556-023-01339-x","volume":"26","author":"A Wang","year":"2024","unstructured":"Wang A, Chen C, Mei C, Liu S, Xiang C, Fang W, Zhang F, Xu Y, Chen S, Zhang Q et al (2024) Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders. Nat Cell Biol 26:219\u2013234","journal-title":"Nat Cell Biol"},{"key":"856_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33535-y","volume":"13","author":"CP Wardlaw","year":"2022","unstructured":"Wardlaw CP, Petrini JHJ (2022) ISG15 conjugation to proteins on nascent DNA mitigates DNA replication stress. Nat Commun 13:5971","journal-title":"Nat Commun"},{"key":"856_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.immuni.2020.06.009","volume":"53","author":"J Wu","year":"2020","unstructured":"Wu J, Dobbs N, Yang K, Yan N (2020) Interferon-independent activities of mammalian STING mediate antiviral response and tumor immune evasion. Immunity 53:115","journal-title":"Immunity"},{"key":"856_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj2102","volume":"10","author":"Q Wu","year":"2024","unstructured":"Wu Q, Leng X, Zhang Q, Zhu Y-Z, Zhou R, Liu Y, Mei C, Zhang D, Liu S, Chen S et al (2024) IRF3 activates RB to authorize cGAS-STING-induced senescence and mitigate liver fibrosis. Sci Adv 10:eadj2102","journal-title":"Sci Adv"},{"key":"856_CR63","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41556-019-0352-z","volume":"21","author":"S Wu","year":"2019","unstructured":"Wu S, Zhang Q, Zhang F, Meng F, Liu S, Zhou R, Wu Q, Li X, Shen L, Huang J et al (2019a) HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity. Nat Cell Biol 21:1027\u20131040","journal-title":"Nat Cell Biol"},{"key":"856_CR64","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s42255-019-0150-8","volume":"1","author":"Z Wu","year":"2019","unstructured":"Wu Z, Oeck S, West AP, Mangalhara KC, Sainz AG, Newman LE, Zhang X-O, Wu L, Yan Q, Bosenberg M et al (2019b) Mitochondrial DNA stress signalling protects the nuclear genome. Nat Metab 1:1209\u20131218","journal-title":"Nat Metab"},{"key":"856_CR65","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1084\/jem.20161524","volume":"214","author":"Y Xiao","year":"2017","unstructured":"Xiao Y, Zou Q, Xie X, Liu T, Li HS, Jie Z, Jin J, Hu H, Manyam G, Zhang L et al (2017) The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. J Exp Med 214:1493\u20131507","journal-title":"J Exp Med"},{"key":"856_CR66","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.cell.2018.07.041","volume":"174","author":"D Xu","year":"2018","unstructured":"Xu D, Jin T, Zhu H, Chen H, Ofengeim D, Zou C, Mifflin L, Pan L, Amin P, Li W et al (2018) TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell 174:1477\u20131491.e19","journal-title":"Cell"},{"key":"856_CR67","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.molcel.2014.11.027","volume":"56","author":"P Xu","year":"2014","unstructured":"Xu P, Bailey-Bucktrout S, Xi Y, Xu D, Du D, Zhang Q, Xiang W, Liu J, Melton A, Sheppard D et al (2014) Innate antiviral host defense attenuates TGF-\u03b2 function through IRF3-mediated suppression of Smad signaling. Mol Cell 56:723\u2013737","journal-title":"Mol Cell"},{"key":"856_CR68","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0959-8049(01)00230-1","volume":"37","author":"Y Yarden","year":"2001","unstructured":"Yarden Y (2001) The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer 37:S3\u2013S8","journal-title":"Eur J Cancer"},{"key":"856_CR69","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrc3309","volume":"12","author":"Y Yarden","year":"2012","unstructured":"Yarden Y, Pines G (2012) The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer 12:553\u2013563","journal-title":"Nat Rev Cancer"},{"key":"856_CR70","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1158\/1078-0432.CCR-13-1559","volume":"20","author":"T Yoshida","year":"2014","unstructured":"Yoshida T, Zhang G, Smith MA, Lopez AS, Bai Y, Li J, Fang B, Koomen J, Rawal B, Fisher KJ et al (2014) Tyrosine phosphoproteomics identified both co-drivers and co-targeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer. Clin Cancer Res 20:4059\u20134074","journal-title":"Clin Cancer Res"},{"key":"856_CR71","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","volume":"183","author":"C-H Yu","year":"2020","unstructured":"Yu C-H, Davidson S, Harapas CR, Hilton JB, Mlodzianoski MJ, Laohamonthonkul P, Louis C, Low RRJ, Moecking J, De Nardo D et al (2020) TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS. Cell 183:636\u2013649.e18","journal-title":"Cell"},{"key":"856_CR72","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0709662105","volume":"105","author":"C-H Yun","year":"2008","unstructured":"Yun C-H, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong K-K, Meyerson M, Eck MJ (2008) The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci USA 105:2070\u20132075","journal-title":"Proc Natl Acad Sci USA"},{"key":"856_CR73","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","volume":"567","author":"C Zhang","year":"2019","unstructured":"Zhang C, Shang G, Gui X, Zhang X, Bai X-C, Chen ZJ (2019) Structural basis of STING binding with and phosphorylation by TBK1. Nature 567:394\u2013398","journal-title":"Nature"},{"key":"856_CR74","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41556-022-00894-z","volume":"24","author":"D Zhang","year":"2022","unstructured":"Zhang D, Liu Y, Zhu Y, Zhang Q, Guan H, Liu S, Chen S, Mei C, Chen C, Liao Z et al (2022) A non-canonical cGAS\u2013STING\u2013PERK pathway facilitates the translational program critical for senescence and organ fibrosis. Nat Cell Biol 24:766\u2013782","journal-title":"Nat Cell Biol"},{"key":"856_CR75","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/ncb3496","volume":"19","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Meng F, Chen S, Plouffe SW, Wu S, Liu S, Li X, Zhou R, Wang J, Zhao B et al (2017) Hippo signalling governs cytosolic nucleic acid sensing through YAP\/TAZ-mediated TBK1 blockade. Nat Cell Biol 19:362\u2013374","journal-title":"Nat Cell Biol"},{"key":"856_CR76","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S1470-2045(24)00379-6","volume":"25","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, He Y, Wang W, Cai Q, Ge F, Chen Z, Zheng J, Zhang Y, Deng H, Chen Y et al (2024) Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis. Lancet Oncol 25:1347\u20131356","journal-title":"Lancet Oncol"},{"key":"856_CR77","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.1038\/s44318-024-00244-9","volume":"43","author":"R Zhou","year":"2024","unstructured":"Zhou R, Wang M, Li X, Liu Y, Yao Y, Wang A, Chen C, Zhang Q, Wu Q, Zhang Q et al (2024) TBK1-Zyxin signaling controls tumor-associated macrophage recruitment to mitigate antitumor immunity. EMBO J 43:4984\u20135017","journal-title":"EMBO J"},{"key":"856_CR78","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41556-019-0429-8","volume":"21","author":"L Zhu","year":"2019","unstructured":"Zhu L, Li Y, Xie X, Zhou X, Gu M, Jie Z, Ko C-J, Gao T, Hernandez BE, Cheng X et al (2019) TBKBP1 and TBK1 form a growth factor signaling axis mediating immunosuppression and tumorigenesis. Nat Cell Biol 21:1604\u20131614","journal-title":"Nat Cell Biol"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00856-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44318-026-00856-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00856-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:31:47Z","timestamp":1786948307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44318-026-00856-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":80,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8,17]]}},"alternative-id":["856"],"URL":"https:\/\/doi.org\/10.1038\/s44318-026-00856-3","relation":{},"ISSN":["1460-2075"],"issn-type":[{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}